Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2022-02-07 Regulatory Filings
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomed Announces Clinical Trial Results
Regulatory Filings Classification · 95% confidence The document is a press release announcing the results of a clinical trial for a medical device (Aurora AEYE). It does not fit into financial reporting categories like 10-K or IR, nor is it a report publication announcement (RPA) as it provides the actual results rather than just announcing the availability of a report. Since it is a regulatory announcement regarding company operations and product development that does not fit into specific categories like M&A or dividends, it falls under the general regulatory filing category.
2022-02-07 English
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholdings, specifically citing 'Chapter 9, Section 10 of the Securities Markets Act'. It details the decrease in holdings by BI Asset Management Fondsmægler-selskab A/S in Optomed Plc. This falls under the definition of a Major Shareholding Notification (MRQ), which tracks changes in significant ownership levels.
2022-01-28 English
Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding (flagging notification) under the Finnish Securities Markets Act (Arvopaperimarkkinalaki). It details that BI Asset Management Fondsmægler-selskab A/S has crossed a threshold in their ownership of Optomed Oyj shares. This type of disclosure is specifically categorized as a Major Shareholding Notification (MRQ).
2022-01-28 Finnish
Proposal of Optomed’s Nomination Board
AGM Information Classification · 98% confidence The document is a 'Stock Exchange Release' from Optomed Plc detailing the proposals of the Nomination Board regarding the composition and remuneration of the Board of Directors for the upcoming Annual General Meeting. This type of document, which outlines board nominations and compensation proposals ahead of a shareholder meeting, is classified as Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on these specific agenda items.
2022-01-25 English
Optomedin osakkeenomistajien nimitystoimikunnan ehdotus
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a stock exchange release ('Pörssitiedote') from Optomed Oyj detailing the proposals of the Shareholders' Nomination Board regarding the upcoming Annual General Meeting (AGM). It covers the number of board members, nominations for board members, and remuneration proposals. Since these are materials prepared for the AGM and shared with shareholders to inform them of upcoming voting items, it falls under the category of Proxy Solicitation & Information Statement (PSI).
2022-01-25 Finnish
Change in Optomed’s holding of treasury
Transaction in Own Shares Classification · 100% confidence The document is a short stock exchange release announcing a change in the company's treasury shares due to stock option plan subscriptions. This falls under the category of a company buying back or selling/issuing its own shares, which is classified as 'Transaction in Own Shares'.
2021-11-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.